S D IRELAND CANCER RESEARCH FUND I… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Legal Domicile

Principal Officer

KIMBERLY IRELAND

Phone

8028636222

Tax Period

2023-01-01 to 2023-12-31

S D IRELAND CANCER RESEARCH FUND INC is a community nonprofit in the Philanthropy & Grantmaking sector that reported $2.3M in total revenue in fiscal year 2023. Revenue fell 26% from the prior year — a significant decline worth monitoring. Expenses of $3.2M exceeded revenue, resulting in a 35% operating deficit.

Mission

TO RAISE FUNDS WHICH ARE THEN DONATED FOR THE PURPOSE OF CANCER RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $600,489

DONATED FUNDS TO THE UVM MEDICAL CENTER FOR CANCER RESEARCH

Program 2

Expenses: $30,000

DONATED FUNDS TO THE GEISEL SCHOOL OF MEDICINE AT DARTMOUTH FOR CANCER RESEARCH

Program 3

Expenses: $2,524,975

DONATED FUNDS TO MOONSHOT ANTIBODIES LLC FOR CANCER RESEARCH

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,212,470

Program Service Revenue $0

Investment Income $123,412

Other Revenue $0

TOTAL REVENUE $2,335,882

Expense Breakdown

Grants Paid $3,154,975

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $3,155,464

Other Expenses $489

TOTAL EXPENSES $3,155,464

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,335,882	$3,144,527	-0.3%
Expenses	$3,155,464	$490,300	+5.4%
Net Income	$-819,582	$2,654,227	-1.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KIMBERLY IRELAND	VP, SEC & DI	2.00	Officer Director	$0	$0	$0
SCOTT D IRELAND	PRESIDENT &	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,335,882	$3,155,464	$2,204,745	$-819,582

S D IRELAND CANCER RESEARCH FUND INC